Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Healthcare & Medical Investment (TSE:3455) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Healthcare & Medical Investment EBITDA Margin % Related Terms
Healthcare & Medical Investment EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Healthcare & Medical Investment EBITDA Margin % Chart
TSE:3455 vs WELL, VTR, OHI: EBITDA Margin % Comparison
For the REIT - Healthcare Facilities subindustry, Healthcare & Medical Investment's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Healthcare & Medical Investment EBITDA Margin % vs REITs Industry
For the REITs industry and Real Estate sector, Healthcare & Medical Investment's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Healthcare & Medical Investment's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Healthcare & Medical Investment (TSE:3455) has a EBITDA Margin % of 72.35% as of Jan. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Healthcare & Medical Investment and its competitors. This is near median its historical median of 71.96. Over the past decade, Healthcare & Medical Investment's EBITDA Margin % has ranged from 70.10 to 75.45. According to the industry distribution chart, Healthcare & Medical Investment ranks #338 out of 735 companies in the REITs industry, placing it in the top 46%.
Is Healthcare & Medical Investment's EBITDA Margin % too high?
Healthcare & Medical Investment's current EBITDA Margin % of 72.35% is near median its 10-year median of 71.96. Over the past 10 years, this metric has ranged from a low of 70.10 to a high of 75.45. The REITs industry median EBITDA Margin % is 69.63. Healthcare & Medical Investment's value of 72.35% is 3.9% above this industry median. Based on the distribution chart, Healthcare & Medical Investment ranks #338 out of 735 companies in the REITs industry, which is above the industry midpoint. Overall, Healthcare & Medical Investment has a GF Score™ of 59/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Healthcare & Medical Investment's EBITDA Margin % compare to WELL and VTR?
According to the REITs industry distribution chart, Healthcare & Medical Investment ranks #338 out of 735 companies for EBITDA Margin %. This puts Healthcare & Medical Investment in the upper half of its industry. The industry median EBITDA Margin % is 69.63. Healthcare & Medical Investment's value of 72.35% is 3.9% above this benchmark. Historically, Healthcare & Medical Investment's own EBITDA Margin % has ranged from 70.10 to 75.45 over the past decade. While the company's 10-year median is 71.96 vs. the industry median of 69.63, Healthcare & Medical Investment has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a REITs company?
The median EBITDA Margin % among REITs companies is 69.63, based on 735 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Healthcare & Medical Investment's current EBITDA Margin % of 72.35% is 3.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Healthcare & Medical Investment and its competitors. For the REITs industry, the median EBITDA Margin % is 69.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Healthcare & Medical Investment's current EBITDA Margin % is 72.35%, which is near median its own 10-year median of 71.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healthcare & Medical Investment stock overvalued right now?
Based on GuruFocus' analysis, Healthcare & Medical Investment (TSE:3455) is currently considered Modestly Undervalued. The stock's GF Value™ is 円129,254.71, compared to a current price of 円105,400.00 — trading 18.5% below its estimated fair value. The current EBITDA Margin % is 72.35%, which is near median its 10-year median of 71.96 and 3.9% above the REITs industry median of 69.63. Healthcare & Medical Investment's overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Healthcare & Medical Investment (TSE:3455), the current EBITDA Margin % is 72.35% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Healthcare & Medical Investment (TSE:3455) Overvalued in 2026?
Based on GuruFocus' analysis, Healthcare & Medical Investment stock appears to be undervalued.
The current stock price of 円105,400.00 is trading 18.5% below its estimated GF Value™ of 円129,254.71.
GuruFocus considers Healthcare & Medical Investment to be Modestly Undervalued.
Key valuation signals for TSE:3455:
EBITDA Margin %: 72.35% (near median its 10-year median of 71.96)
GF Value™: 円129,254.71 vs. price of 円105,400.00 (18.5% below fair value)
Industry Position: 3.9% above the REITs median (#338 of 735)
No single metric tells the full story. See the TSE:3455 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Healthcare & Medical Investment Corp is an investment company, which invests in nursing homes facilities and medical related real properties. The company aims to achieve stable earnings from mid- to long-term perspectives through investment in real estate and other related assets. The firm primarily invests in facilities and buildings for the elderly, as well as medical related facilities.
59GF Score
Get the complete analysis for TSE:3455
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3455 has been successfully added to your 
